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Abstract
Objectives—To explore the prevalence of Orofacial Pain (OFP) among patients with Vulvar
Vestibulitis Syndrome (VVS) and to examine the relationship between signs and symptoms of OFP
and clinical characteristics of women with VVS; we specifically sought to investigate differences in
psychological characteristics and self-reported severity of painful intercourse.
Methods—In this cross-sectional exploratory study, 137 women with VVS completed
questionnaires that assessed self-reported levels of pain, anxiety, somatization, and presence of signs
and symptoms suggestive of clinical and sub-clinical OFP. Demographic data were gathered from
medical records.
Results—Orofacial Pain was found to be a highly prevalent (78%) condition among women with
VVS. Compared to women with no OFP symptoms (n=30), those with symptoms (n=64) had higher
levels of anxiety (45.0 vs. 37.8, Bonferroni adjusted p=0.017), somatization (125.2 vs. 96.0,
Bonferroni adjusted p<0.001), and psychological distress (62.8 vs. 56.0, Bonferroni adjusted
p=0.002). While we observed a similar trend among women with sub-clinical OFP (n=43), this trend
only reached statistical significance with respect to somatization. Differences were not detected for
demographics, duration of pain, and severity of pain during intercourse across the three groups.
Discussion—Orofacial Pain is a common condition among women with VVS. Because severity
and duration of painful intercourse did not differ by OFP classification but psychological
characteristics did, we must begin to question a uni-dimensional focus on vestibular mucosa as a
reason for pain and persistent distress.
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Introduction
Vulvar Vestibulitis Syndrome (VVS), the most common type of chronic vulvovaginal pain,
impairs the psychological, physical, and reproductive health of nearly 1 in 10 women at some
point in their lifetime.1 VVS is also known as localized vulvodynia, vestibulodynia, and, in
2004, was renamed as “provoked localized vulvodynia” by the International Society for the
Study of Vulvovaginal Disease (ISSVD).2, 3 However, the clinical diagnosis of VVS has not
changed since it was originally introduced by Friedrich,4 and is based on self-report of severe
pain upon vaginal entry and tenderness to pressure localized within the vulvar mucosa
(vestibule).5 To date, the etiology of VVS remains poorly understood, and the diagnosis is
made after excluding other known gynecological disorders in the face of persistent pain with
genital contact (e.g., tampon use or intercourse).6
Although the current definition of VVS is based on a local pain conceptualization of this
condition, an emerging body of evidence supports the notion of VVS as a complex pain
disorder, akin to idiopathic musculoskeletal pain conditions, such as fibromyalgia and
temporomandibular disorder 6, 7 In addition to higher pain on mucosal (vestibular) contact,
women with VVS show increased pain sensitivity in non-genital sites.6 A higher prevalence
of psychological traits, such as somatization and anxiety, are also well documented in this
population.6 Collectively these observations suggest that women with VVS may have an
alteration in pain processing pathways. In addition, these women may have psychological
characteristics that facilitate the development of pain.6, 7
Granot and colleagues were the first to investigate the relationship between alterations in pain
processing pathways- as demonstrated by heightened non-genital pain sensitivity- and
psychological traits (such as anxiety) with treatment outcomes. They made an important
observation in that subgroups of women with VVS differed in self-reports of anxiety,
somatization and non-genital pain sensitivity.8-10 Additionally, in their study, women with
higher non-genital pain sensitivity and anxiety tended to respond poorly to conventional
treatments for VVS.8 This work, as well as that of others,11-14 has led to a gradual shift away
from the traditional conceptualization of VVS as primarily a mucosal inflammatory process.
We hypothesize that VVS is a group of disorders characterized by dysfunctions in the vestibular
mucosa (i.e., heightened inflammatory response) and central pain processing pathways.
However, the extent to which these dysfunctions contribute to the overall clinical picture varies
among individuals.
In this study, we aimed to explore the overlap between Orofacial Pain (OFP) and VVS. We
embarked on this study after noticing that a high percentage of women with VVS seen in our
clinics complained of a distinct pattern of pain in their orofacial regions which was suggestive
of an idiopathic pain condition such as temporomandibular disorder. We also noted that
compared to women with no orofacial pain, those women with orofacial pain were more likely
to report pelvic muscle tenderness during gynecological examination with an inability to relax
pelvic muscles.
After consultation with colleagues in orofacial pain research, we used a validated questionnaire
to investigate the prevalence of signs/symptoms suggestive of OFP in our cohort of women
with VVS. In addition, we investigated the relationship between OFP and self-reported pain
during intercourse, as well as its association with psychological characteristics such as anxiety,
somatization, and distress.
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Materials and Methods
This cross-sectional questionnaire study was conducted between February 1, 2003 and October
31, 2005, and was approved by the institutional review board at the University of North
Carolina at Chapel Hill. Women diagnosed with VVS during or after January 2002 were
eligible for participation. In our clinical practice, the diagnosis of VVS is made by a subjective
report of pain during intercourse and tenderness to touch elicited during a cotton swab exam;
this diagnosis is only rendered after excluding other identifiable gynecological disorders.5
Among participants, the diagnosis of VVS was confirmed by the review of medical records by
two independent reviewers. Both reviewers were blinded to the subjects’ responses to the
questionnaires. In addition to confirming the diagnosis of VVS, the reviewers assessed
eligibility. Disagreements on eligibility (n=4) were adjudicated by a third reviewer. Women
who had VVS with other urogenital pain disorders (e.g., vaginismus, generalized vulvodynia,
interstitial cystitis), dermatologic conditions (e.g., lichen sclerosis), chronic pelvic pain defined
as non-menstrual daily pain localized to the pelvic region, and neuropathies (e.g., pudendal
neuralgia) were excluded. A total of 196 women were eligible for participation and received
both the consent forms and questionnaires. Participants were instructed by a cover letter in the
study package to return the completed questionnaires and consent documents in a pre-stamped
envelope. Of the 196 eligible women, 137 (70%) completed the questionnaires and comprise
our sample.
The battery of questionnaires included assessments for psychological characteristics and self-
reported pain. Additionally, participants were asked to complete a 9-item, validated
questionnaire in order to assess signs and symptoms suggestive of OFP (e.g.,
temporomandibular disorder). Characteristics of the questionnaire are reviewed below.
Pain Questionnaire
Self-reported pain with intercourse was assessed by administering the Gracely Pain Scale,
which asks women to rate the lowest, average and maximal pain with intercourse on a scale of
0−100.15 Participants are instructed to select verbal descriptors of their pain by circling a word
that best describes their pain experience. These verbal descriptors capture two important pain
domains: 1) sensory (severity of physical pain), and 2) affective (emotional response to a given
level of physical pain). A predetermined numerical value for each verbal descriptor was
averaged to obtain a summary score for statistical analysis. Modified versions of this
questionnaire are commonly used in assessing pain among patients with idiopathic pain
disorders (e.g., temporomandibular disorder and fibromyalgia).
Psychological Questionnaires
We administered questionnaires to assess anxiety (Speilberger State-Trait Anxiety
Inventory), somatization (Pennebaker Inventory of Limbic Languidness), and global
psychological distress (Brief Symptom Inventory-Global Severity Index). The following is a
brief description of these questionnaires.
The State-Trait Anxiety Inventory (STAI) consists of two 20-item questionnaires, which assess
an individual's current anxiety level and general propensity towards anxiety. This instrument
has good reliability (retest reliability: r=.73 to .86, Cronbach's α=0.83 to 0.92) and is widely
utilized in clinical research;16 the norm for a female population of comparable demographics
is 36 on both scales. As a comparison, the average score of an inpatient neuropsychiatric
population is 47.7 and 46.6, respectively for the state and trait anxiety scales.16
The Pennebaker Inventory of Limbic Languidness (PILL) assesses somatization by capturing
the frequency of occurrence of 54 common physical symptoms and sensations. It has high
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internal consistency (α=0.88) and adequate test-retest reliability (0.70 for a two-month period);
17 the norm for the female population is 98−104. A high baseline somatization score is an
independent risk factor for the development of a chronic pain state7 and is shown to correlate
well with the number of tender muscle sites, pain sensitivity and progression to chronicity.18
The Brief Symptom Inventory (BSI) consists of 53 items rating psychological distress in nine
areas: somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety,
hostility, phobic anxiety, paranoid ideation, and psychoticism.19 A global severity index (GSI)
is obtained by combining the number and intensity of reported symptoms. Internal consistency
using Cronbach's α ranges from a low of 0.75 (psychoticism) to a high of 0.85 (depression).
Test-retest validity for the global severity index score is 0.90;19 the norm for the female
population is 50, with a clinical cut-off of 63.20
Lastly, to examine the prevalence of signs and symptoms suggestive of idiopathic pain
disorders in the orofacial region, we administered a 9-item, validated screening survey. This
survey is commonly used to identify incident cases of temporomandibular disorder, and is
validated against the ‘gold standard’ physical exam; the sensitivity (100%) and specificity
(81%) of this screening survey is high (G. D. Slade, PhD, unpublished data, November, 2005).
Participants are queried on the frequency and duration of symptoms such as headache, facial
and jaw pain, grinding, and clenching. Two independent reviewers (DZ and WM) masked to
the subjects’ identification and responses to psychometric questionnaires classified women
into the following three categories: OFP, sub-clinical OFP, or no OFP. We classified women
as having OFP if they had been previously been diagnosed with temporomandibular disorder
or endorsed greater than three episodes of headache or ‘sinus pain’ per week, and experienced
both provoked and spontaneous orofacial pain. We classified women as having sub-clinical
OFP if they denied spontaneous orofacial pain but endorsed provoked orofacial pain, and
reported greater than three episodes of headache or ‘sinus pain’ per week. In addition, in order
to be classified in the sub-clinical OFP category, subjects had to report use of night guard,
grinding or clenching. The agreement between the two reviewers was high (Weighted Kappa
(κ) = 0.81, 95% CI (0.71, 0.90)). OFP was defined using three categories instead of two (OFP
versus not) due to our a priori hypothesis that a large proportion of patients would not fit into
either dichotomous category. This hypothesis was based on our previous clinical experience
and a common belief among most pain experts that patients with these conditions represent a
spectrum of disease rather than a dichotomy.
Data Analysis
Statistical analysis was performed using SAS software (version 9.1; SAS Institute Inc., Cary,
NC). We performed bivariate analyses using one way analysis of variance (ANOVA) or
Fisher's Exact tests to determine if there were differences in patient characteristics amongst
the groups classified by OFP (OFP, sub-clinical OFP, no OFP). These characteristics include
age, race, education, parity, marital status, duration of pain, and number of prior physicians
seen for similar symptoms. Differences in mean intercourse related pain (Gracely Pain Severity
Scale) and psychometric assessments were compared for all groups using the ANOVA test.
All tests comparing the three groups were conducted at α=0.05. If overall differences were
detected (p<0.05), Bonferroni procedures were used to adjust the p-values resulting from
multiple pairwise comparisons tests (p-valueBon,adj)
Results
Seventy-eight percent (n=107) of the participants had signs and symptoms suggestive of
idiopathic pain conditions in the orofacial region (e.g., temporomandibular disorder). Of those,
thirty-one percent (n=43) were classified as having sub-clinical OFP and forty-seven percent
(n=64) were classified as having OFP. Demographic characteristics among these subgroups
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did not differ (Table 1). In general, participants were highly educated, young, Caucasian
women with an average duration of 5 years of painful intercourse. We did not observe any
differences with respect to the duration and severity of self-reported pain during intercourse
among the subgroups of women with VVS. Similarly, verbal descriptors indicating sensory
and affective domains of pain during intercourse did not differ among the subgroups (Table
1).
However, we observed significant and robust differences in the psychological characteristics
among the three subgroups (Table 2). Among our cohort of women with VVS, those with OFP
had significantly higher levels of anxiety (Speilberger State-Trait Anxiety Inventory),
somatization (Pennebaker Inventory of Limbic Languidness) and global psychological distress
(Brief Symptom Inventory-Global Severity Index) as compared to those without OFP (Table
2).
Women with OFP had the highest scores on all measured psychometric indices, while those
without OFP had the lowest. Women with sub-clinical OFP, however, consistently fell within
these two limits. For example, while women with sub-clinical OFP were similar to those
without OFP with respect to psychological distress (BSI-Global Severity Index), they differed
significantly on somatization (PILL, Table 2). The highest mean score on somatization was
seen among women with OFP (125.2, 2 SD above norm), followed by women with sub-clinical
OFP (111, 1 SD above norm). Women without OFP had mean score lower than average for
the general population (103.3) (Table 2).
Discussion
In our cohort, approximately 8 out of 10 women with VVS had chronic orofacial pain. The
most common and widely studied form of chronic orofacial pain -temporomandibular disorder-
affects 7−15% of the adult population; 80% of the treated cases are women in their early to
mid-adulthood.21 At the present, we can not irrefutably make a statement about the prevalence
of a specific category of OFP. However, on formal evaluation by an orofacial pain specialist
(as part of an ongoing follow up study) the majority of our participants have signs and
symptoms of temporomandibular disorder.
It is intuitively perplexing as to why an idiopathic orofacial pain disorder (affecting 10% of
the general population)22 is highly prevalent among women with idiopathic genital pain.
Another related question that comes to mind is the mechanism by which the distribution of
signs and symptoms of OFP mirror the spectrum of psychological characteristics among
women with VVS. Women with VVS and symptoms of OFP had higher levels of anxiety,
somatization, and psychological distress; duration and severity of self-reported pain with
intercourse did not differ among categories of OFP.
The association between psychological traits and OFP among women with VVS may, in part,
be explained by specific genetic variants which mediate the activities of central pain regulatory
pathways. For example, polymorphism of the gene encoding catechol-o-methyltransferase
(COMT) is a potent and independent risk factor for the development of chronic pain conditions,
such as temporomandibular disorder.23 Furthermore, the associations between the haplotype
variations for the β2 adrenergic receptor and psychological traits, such as anxiety and
somatization, have been identified.24
We hypothesize that subgroups of women with VVS may share the same genetic vulnerability
as women with temporomandibular disorder.7 Thus, the associations between certain
psychological traits and signs/symptoms of OFP among women with VVS suggest that an
inherent susceptibility may permit or even precede the development of VVS in certain women.
We therefore speculate that women with VVS are a heterogeneous population and that the
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observed clinical phenotype is composed of several interactive biological and psychological
factors.
Based on our findings and an emerging body of evidence, we hypothesize that the experience
of pain with attempted intercourse may be governed by two interdependent processes: 1) a
biologic impairment in pain regulatory mechanisms (similar to what is seen among women
with temporomandibular disorder and other idiopathic pain conditions), and 2) a genetic
predisposition to a heightened inflammatory response in vulvar mucosa. Mucosal sensitivity,
though a necessary component of the clinical manifestation of VVS, may not be sufficient for
the development of this disorder in all women. Experience of pain, though clinically similar,
could in fact be primarily driven by different pathophysiologic processes, some that are
centrally mediated (i.e., biochemical abnormality in pain processing) and some that are
peripherally mediated (i.e., biochemical abnormality in the inflammatory cascade in the
mucosa).
While these results are intriguing, it is important to note that our population reflects the severe
end of the spectrum of patients with VVS seen in a referral-based university clinic. The findings
from our patient population may not be generalizable to VVS patients seen in primary care.
Furthermore, the 137 women who completed the questionnaires that allowed classification of
OFP status may differ in important ways from those not reached or not willing to participate
in research. It is difficult to hypothesize the direction of bias due to non-response. However,
it is unlikely that women who opted against participation or could not be contacted would
change our findings because the classification of these women would likely fall equally among
the three subgroups. Lastly, we did not use the ‘gold standard’22 clinical exam for diagnosis
of OFP but instead used a validated questionnaire used to identify temporomandibular disorder,
the most common form of OFP. This may have resulted in a higher prevalence of OFP.
However, the differences across groups with respect to psychosocial variables are in agreement
with previous research in temporomandibular disorder 25and support the likelihood that our
categories based on questionnaire responses adequately classified OFP groups.
This study is cross-sectional and therefore temporal sequence cannot be established. Specific
psychological traits may precede or be modified by chronic pain disorders.6 Psychological
traits may be consequences of living with chronic pain; more importantly, however, such traits
may precede the development of chronic pain and be amplified with disease progression.
Research in chronic pain disciplines (e.g., orofacial pain, fibromyalgia) requires conceptual
models that examine the interplay between psychological and biological factors and their
ultimate effect on pain pathophysiology. This model is lacking in VVS. Our findings provide
additional evidence in support of VVS being an idiopathic pain disorder akin to fibromyalgia
and TMD. To that end, we must: 1) objectively measure the clinical presentation of VVS as it
relates to the vulvar mucosa, pelvic floor muscles, psychological traits, and central pain
processing mechanisms; 2) investigate the potential for distinctive subtypes of VVS; and 3)
develop a conceptual framework, incorporating these measures, in order to guide research in
the pathophysiology and treatment of VVS.
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